Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
PG1-H5255 | Human | Human CD44 Protein, Fc Tag (HPLC-verified) | ![]() |
![]() ![]() ![]() ![]() |
![]() ![]() |
CD4-H5226 | Human | Human CD44 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Human CD44, His Tag (Cat. No. CD4-H5226) at 5 μg/mL (100 μL/well) can bind Hyaluronan biotin sodium salt with a linear range of 39-156 ng/mL (Routinely tested).
The purity of Human CD44, Fc Tag (HPLC-verified) (Cat. No. PG1-H5255) was greater than 90% as determined by SEC-HPLC.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Clodronic acid/Hyaluronic acid | Phase 1 Clinical | Abiogen Pharma Spa | Osteoarthritis | Details | |
Hyaluronic acid/Fluorouracil | HA-5FU; HA-5-fluorouracil; Hyaluronic acid-5-fluorouracil complex; Hyaluronan acid-5-fluorouracil complex | Phase 2 Clinical | Monash University, Alchemia | Colorectal Neoplasms | Details |
CA-102N | CA-102N | Phase 1 Clinical | Biobud | Solid tumours; Colorectal Neoplasms | Details |
Multiple 4SCAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Breast Neoplasms | Details | |
Paclitaxel/Hyaluronic acid | Phase 3 Clinical | Fidia Pharma | Carcinoma, Papillary; Urinary Bladder Neoplasms | Details | |
Hydrogen peroxide/Hyaluronic acid | BMG-0703 | Phase 3 Clinical | University Of Milan | Wounds and Injuries | Details |
AMC-303 | AMC-303; HP-558 | Phase 1 Clinical | Amcure | Solid tumours; Esophageal Squamous Cell Carcinoma | Details |
CD44v6-specific CAR gene-engineered T cell therapy (Shenzhen Geno-Immune Medical Institute) | 4SCAR-CD44v6 | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Neoplasms | Details |
Hyaluronic acid | ETX-100; CTX-100 | Phase 2 Clinical | Actelion Pharmaceuticals Ltd | alpha 1-Antitrypsin Deficiency; Asthma; Osteoarthritis, Knee | Details |
This web search service is supported by Google Inc.